Area of research
Immunology · Rheumatology
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Cytokine Signaling Pathways and Interactions, and Dermatology and Skin Diseases.
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: a phase Ib, randomized, double-blind, placebo-controlled study
Current status of generalized pustular psoriasis: Findings from a multicenter hospital-based survey of 127 Chinese patients
Efficacy and safety of supramolecular salicylic acid in the treatment of papulopustular rosacea: a multicentre randomized, double-blind, placebo-controlled superiority study
Sequential requirements for distinct Polθ domains during theta-mediated end joining
SPRR1B is Related to the Immune Microenvironment and Can Be Used as a Biomarker for the Diagnosis of Psoriasis
Application of injectable hydrogels in cancer immunotherapy
Hemoporfin-mediated photodynamic therapy for the treatment of port-wine stain: A multicenter, retrospective study
Increase of ISG15 in psoriasis lesions and its promotion of keratinocyte proliferation via the Hif‐1α signalling pathway
Clinical practice Guidelines for 5-Aminolevulinic acid photodynamic therapy for acne vulgaris in China
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis
A Randomized, Double-Blind Phase III Study to Demonstrate the Clinical Similarity of Biosimilar SCT630 to Reference Adalimumab in Chinese Patients with Moderate to Severe Plaque Psoriasis
Bacterial Outer Membrane‐Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram‐Negative Bacterial Infection In Vivo
Fight bacteria with bacteria: Bacterial membrane vesicles as vaccines and delivery nanocarriers against bacterial infections
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study
Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial
MiR-876-5p suppresses cell proliferation by targeting Angiopoietin-1 in the psoriasis
Associations between STAT Gene Polymorphisms and Psoriasis in Northeastern China
Low-dose UVB irradiation prevents MMP2-induced skin hyperplasia by inhibiting inflammation and ROS
Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice
Study on susceptibility genes of psoriasis
High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China
A large-scale screen for coding variants predisposing to psoriasis
Exploration and analysis of Humanistic Care for Patients with Psoriasis
Zhongguo yixue lunlixue 2013cited by 0position: first
Expression of lymphotoxin-β and its receptor in the skin of a mouse model of allergic contact dermatitis